Lack of association of IDH1, IDH2 and DNMT3A mutations with outcome in older patients with acute myeloid leukemia treated with hypomethylating agents

Courtney D. DiNardoDepartment of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]

Keyur P. PatelDepartment of Hematopathology, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Guillermo Garcia-ManeroDepartment of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Rajyalakshmi LuthraDepartment of Hematopathology, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Sherry PierceDepartment of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Gautam BorthakurDepartment of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Elias JabbourDepartment of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Tapan KadiaDepartment of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Naveen PemmarajuDepartment of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Marina KonoplevaDepartment of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Stefan FaderlDepartment of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Jorge CortesDepartment of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Hagop M. KantarjianDepartment of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Farhad RavandiDepartment of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

show all

Click to increase image sizeClick to decrease image size

Potential conflict of interest:

Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Lack of association of IDH1, IDH2 and DNMT3A mutations with outcome in older patients with acute myeloid leukemia treated with hypomethylating agents

Information for

Open access

Opportunities

Help and information

Lack of association of IDH1, IDH2 and DNMT3A mutations with outcome in older patients with acute myeloid leukemia treated with hypomethylating agents

Potential conflict of interest:

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature